Low peak exotherm curable compositions

Abstract

Compositions having a curable unsaturated compound, an adhesion promoter and curing agent which have a peak exotherm of less than 50.degree. C. are disclosed. The compositions when cured are flexible bioadhesives which are also disclosed. Non-curable diluents can be included in the compositions. Flexible bioadhesives formed on biological structures and having low peak exotherms upon curing of curable compositions to form the flexible bioadhesives are disclosed. Compositions having a curable unsaturated compound and a curing agent and a peak exotherm of less than 50.degree. C. are included in the invention.

1 - 55 . (canceled)  
     
     
         56 . A composition comprising: 
 a compound having an unsaturation index of at least about 500;    a curing agent;    an adhesion promoter; and    a therapeutic ingredient;    wherein the composition is curable and has a peak exotherm of less than about 50° C. (120° F.).    
     
     
         57 . A composition according to  claim 56 , further comprising a non-curable diluent.  
     
     
         58 . A composition according to  claim 56 , wherein the curable unsaturated compound comprises at least one unsaturated group selected from the group consisting of methacrylate, acrylate, vinyl and combinations thereof.  
     
     
         59 . A composition according to  claim 58 , wherein the unsaturated group is methacrylate.  
     
     
         60 . A composition according to  claim 56 , wherein the curable unsaturated compound is an oligomer.  
     
     
         61 . A composition according to  claim 60 , wherein the oligomer is a dimethacrylate oligomer.  
     
     
         62 . A composition according to  claim 61 , wherein the dimethacrylate oligomer is a dimethacrylate polyetherurethane oligomer.  
     
     
         63 . A composition according to  claim 56 , wherein the peak exotherm is from about 20° C. to about 45° C.  
     
     
         64 . A composition according to  claim 56 , wherein the peak exotherm is from about 35° C. to about 40° C.  
     
     
         65 . A composition according to  claim 56 , wherein the adhesion promoter is selected from the group consisting of poly(acrylic acid), poly(ethylene oxide), poly(vinyl pyrollidone), poly(maleic anhydride-co-methyl vinyl ether), karaya gum, guar gum, acacia gum, carboxypolymethylene, chitosan, hydroxyethyl cellulose, sodium carboxymethylcellulose, hydroxypropyl cellulose, polycarbophil, poly(vinyl alcohol), hydroxypropylmethyl cellulose and compatible combinations thereof.  
     
     
         66 . A composition according to  claim 56 , wherein the adhesion promoter is polycarbophil.  
     
     
         67 . A composition according to  claim 56 , wherein the curing agent is a photoinitiator.  
     
     
         68 . A composition according to  claim 56 , further comprising a bioadhesion synergist.  
     
     
         69 . A composition according to  claim 68 , wherein the bioadhesion synergist is a divalent metal or an alkali metal ion.  
     
     
         70 . A composition according to  claim 56 , wherein after curing the composition is a flexible bioadhesive.  
     
     
         71 . A composition according to  claim 56 , further comprising a curing agent synergist.  
     
     
         72 . A composition according to  claim 71 , wherein the curing agent synergist is ethyl-4-dimethylaminobenzoate.  
     
     
         73 . A composition according to  claim 56 , further comprising a silica thickener.  
     
     
         74 . A composition according to  claim 56 , wherein the composition is substantially free of monomers.  
     
     
         75 . A composition according to  claim 56 , wherein the composition is monomer free.  
     
     
         76 . A composition according to  claim 57 , wherein the non-curable diluent has a viscosity of from about 1 centipoise to about 2000 centipoise.  
     
     
         77 . A curable composition according to  claim 56 , further comprising a light-attenuating pigment.  
     
     
         78 . A curable composition according to  claim 77 , wherein the light-attenuating pigment is selected from the group consisting of titanium dioxide and zinc oxide.  
     
     
         79 . A composition according to  claim 77 , wherein the light-attenuating pigment is present from about 0.0001 percent to about 10 percent by weight of the composition.  
     
     
         80 . A composition according to  claim 56 , wherein the therapeutic ingredient is an active drug.  
     
     
         81 . A composition according to  claim 56 , wherein the therapeutic ingredient is a medicament.  
     
     
         82 . A two-part system comprising: 
 a) a first part which comprises a curing agent; and    b) a second part which comprises a curing agent synergist of the curing agent of the first part,    wherein the first part or the second part or both further comprises a compound having an unsaturation index of at least 500, a therapeutic ingredient, and an adhesion promoter, and wherein upon mixing of the first part and the second part, curing is achieved with a peak exotherm of less than about 50° C. (120° F.).    
     
     
         83 . A composition according to  claim 82 , wherein the curing agent is a benzoyl peroxide and the curing agent synergist is N,N-dimethyl-p-toluidine.  
     
     
         84 . A composition according to  claim 82 , wherein the therapeutic ingredient is an active drug.  
     
     
         85 . A composition according to  claim 82 , wherein the therapeutic ingredient is a medicament.  
     
     
         86 . A method for forming a flexible bioadhesive on a tissue, comprising: 
 contacting the tissue with a composition comprising a compound having an unsaturation index of at least about 500, a curing agent, a therapeutic ingredient, and an adhesion promoter, wherein the composition is curable and has a peak exotherm of less than about 50° C. (120° F.), and    curing the composition to form the flexible bioadhesive on the tissue.    
     
     
         87 . A composition according to  claim 86 , wherein the therapeutic ingredient is an active drug.  
     
     
         88 . A composition according to  claim 86 , wherein the therapeutic ingredient is a medicament.  
     
     
         89 . A method according to  claim 86 , wherein the tissue is selected from the group consisting of skin, mucosa, internal organs, bone, tendon, cartilage, enamel, dentin, and fingernails.  
     
     
         90 . A flexible bioadhesive on a tissue surface prepared by the method of  claim 86 .  
     
     
         91 . A composition comprising a methacrylated polyetherurethane oligomer, capric/caprylic triglyceride, polycarbophil, camphorquinone, and ethyl-4-dimenthylaminobenzoate.  
     
     
         92 . A composition according to  claim 91 , further comprising fumed silica.  
     
     
         93 . A composition according to  claim 91 , further comprising zinc oxide.  
     
     
         94 . A composition according to  claim 91 , wherein the composition comprises a methacrylated polyetherurethane oligomer in an amount from about 25 percent to about 98 percent by weight based on the total weight of the composition, capric/caprylic triglyceride in an amount from about 2 percent to about 50 percent by weight based on the total weight of the composition, polycarbophil in an amount from about 10 percent to about 50 percent by weight based on the total weight of the composition, camphorquinone in an amount from about 0.05 percent to about 0.30 percent by weight based on the total weight of the composition, and ethyl-4-dimethylaminobenzoate in an amount from about 0.1 percent to about 1.0 percent by weight based on the total weight of the composition.  
     
     
         95 . A composition according to  claim 91 , further comprising a therapeutic ingredient.  
     
     
         96 . A composition according to  claim 95 , wherein the therapeutic ingredient is an active drug.  
     
     
         97 . A composition according to  claim 95 , wherein the therapeutic ingredient is a medicament.  
     
     
         98 . A composition comprising a compound having less than about 40% monomers, an unsaturation index of at least about 500, a curing agent, a therapeutic ingredient, and an adhesion promoter, wherein the composition is curable and has a peak exotherm of less than about 50° C. (120° F.).  
     
     
         99 . A method of making a composition comprising the steps of: 
 selecting a compound having an unsaturation index of at least 500; and    mixing said compound with a curing agent, a therapeutic ingredient, and an adhesion promoter, wherein the mixture is curable and has a peak exotherm of less than about 50° C. (120° F.).    
     
     
         100 . The method of  claim 99 , wherein the curable unsaturated compound comprises less than about 40% monomers.  
     
     
         101 . The method of  claim 99 , wherein the curable unsaturated compound is monomer-free.  
     
     
         102 . A composition according to  claim 99 , wherein the therapeutic ingredient is an active drug.  
     
     
         103 . A composition according to  claim 99 , wherein the therapeutic ingredient is a medicament.